A virological response to PEG-IFNa treatment of hepatitis delta is associated with an improved clinical long-term outcome: 10 years follow-up of the HIDIT-1 study


Wranke A., Yurdaydin C., Heidrich B., Kalliopi Z., Yalcin K., Fehmi T., ...More

International Liver Congress (ILC), Paris, France, 11 - 15 April 2018, vol.68 identifier